Appropriateness of rivaroxaban and apixaban dosing in hospitalized patients with a newly diagnosed nonvalvular atrial fibrillation at a single tertiary hospital

Possible challenges in dosing non-vitamin K antagonist oral anticoagulants in nonvalvular atrial fibrillation (NVAF) and limited evidence in Saudi Arabia make it difficult to assess their appropriateness. This study aimed to assess the appropriateness of prescribing rivaroxaban and apixaban in hospi...

Descripción completa

Detalles Bibliográficos
Autor principal: Alshibani, Mohannad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489303/
https://www.ncbi.nlm.nih.gov/pubmed/37682197
http://dx.doi.org/10.1097/MD.0000000000035058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489303/
https://www.ncbi.nlm.nih.gov/pubmed/37682197
http://dx.doi.org/10.1097/MD.0000000000035058

Ejemplares similares